Login Register Cart 0
Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Detection and Reporting of Adverse Drug Reactions Related to Antibiotics in Primary Healthcare in Greece

Author(s): Mary Geitona , Aikaterini Toska*, Dimitra Latsou and Maria Saridi

Volume 17, Issue 3, 2022

Published on: 20 December, 2021

Page: [217 - 224] Pages: 8

DOI: 10.2174/1574886316666211108103952

open access plus

Abstract

Background: Detection of adverse drug reactions (ADRs) is a challenging matter for healthcare professionals who contribute significantly to the pharmacovigilance system through their participation inspontaneous reporting.

Objective: The objective of this study was the detection and reporting of ADRs related to antibiotics in primary health care in the region of Peloponnese.

Methods: A cross-sectional study was conducted in all national health system primary health units of the Peloponnese region in Greece. A self-administered questionnaire was distributed to a total of 404 physicians who provided services in these settings. Descriptive and multivariate statistical analysis was performed using the SPSS 25.0. Levels of significance were two-tailed and statistical significance was set at p =0.05.

Results: 306 out of 404 physicians responded to the questionnaire, giving a response rate of 75.8%. 81.6% of physicians stated that they rarely observe ADRs related to antibiotic administration during their practice, 49.8% rarely report them, and 33.7% never report them. Non-serious side effects (42.5%), physicians’ workload (24.1%), and the lack of knowledge about the reporting obligation (20.6%) have been declared as the main reasons of non - reporting. In addition, physicians with ≤10 years of clinical practice rarely reported that they experienced ADRs after antibiotics’ administration compared to those with more work experience and specialized physicians (p= 0.001).

Conclusion: ADRs reporting rates among physicians in primary healthcare are low. Changes in physicians’ attitudes are vital and can be achieved through consistent and continuous training programs as well as the inclusion of ADRs and pharmacovigilance themes into the tertiary education curricula.

Keywords: Adverse drug reactions reporting, detection, antibiotics, physicians, primary healthcare, Greece, pharmacovigilance

« Previous Next »
Graphical Abstract

[1]
World Health Organization. Safety monitoring of medicinal products. Guidelines for setting up and running a Pharmacovigilance Centre. 2000. Available from: http://apps.who.int/medicinedocs/en/d/
[2]
Uppsala Monitoring Centre. Glossary of terms used in Pharmacovigilance. Available from: http://www.who-umc.org/
[3]
Molokhia M, Tanna S, Bell D. Improving reporting of adverse drug reactions: Systematic review. Clin Epidemiol 2009; 1: 75-92.
[http://dx.doi.org/10.2147/CLEP.S4775] [PMID: 20865089]
[4]
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 1998; 279(15): 1200-5.
[http://dx.doi.org/10.1001/jama.279.15.1200] [PMID: 9555760]
[5]
Mohamed IN, Helms PJ, Simpson CR, Milne RM, McLay JS. Using primary care prescribing databases for pharmacovigilance. Br J Clin Pharmacol 2011; 71(2): 244-9.
[http://dx.doi.org/10.1111/j.1365-2125.2010.03816.x] [PMID: 21219405]
[6]
Srinivasan R, Ramya G. Adverse drug reaction- causality assessment. IJRPC 2011; 1(3): 2231-781.
[7]
World Health Organization. Safety of medicines - a guide to detecting and reporting adverse drug reactions. 2002. Available at: https://apps.who.int/iris/handle/10665/67378
[8]
Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ 2004; 329(7456): 15-9.
[http://dx.doi.org/10.1136/bmj.329.7456.15] [PMID: 15231615]
[9]
Rodríguez-Monguió R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. PharmacoEconomics 2003; 21(9): 623-50.
[http://dx.doi.org/10.2165/00019053-200321090-00002] [PMID: 12807365]
[10]
Hitchen L. Adverse drug reactions result in 250,000 UK admissions a year. BMJ 2006; 332(7550): 1109.
[http://dx.doi.org/10.1136/bmj.332.7550.1109] [PMID: 16690649]
[11]
Formica D, Sultana J, Cutroneo PM, et al. The economic burden of preventable adverse drug reactions: A systematic review of observational studies. Expert Opin Drug Saf 2018; 17(7): 681-95.
[http://dx.doi.org/10.1080/14740338.2018.1491547] [PMID: 29952667]
[12]
Ewbank L, Omojomolo D, Sullivan K, et al. The rising cost of medicines to the NHS: What’s the story? Briefing 2018.
[13]
Burton MM, Hope C, Murray MD, Hui S, Overhage JM. The cost of adverse drug events in ambulatory care. AMIA Annu Symp Proc 2007; 11: 90-3.
[PMID: 18693804]
[14]
Almandil NB. Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance. Saudi Med J 2016; 37(12): 1359-64.
[http://dx.doi.org/10.15537/smj.2016.12.17059] [PMID: 27874152]
[15]
Pal SN, Duncombe C, Falzon D, Olsson S. WHO strategy for collecting safety data in public health programmes: Complementing spontaneous reporting systems. Drug Saf 2013; 36(2): 75-81.
[http://dx.doi.org/10.1007/s40264-012-0014-6] [PMID: 23329541]
[16]
Hazell L, Shakir SA. Under-reporting of adverse drug reactions : A systematic review. Drug Saf 2006; 29(5): 385-96.
[http://dx.doi.org/10.2165/00002018-200629050-00003] [PMID: 16689555]
[17]
British Medical Association Board of Sciences: Reporting adverse drug reactions- a guide for healthcare professionals. 2006. Available from: http://www.isopouline.org/wp-content/uploads/2015/01/BMAreport
[18]
Balidemaj F. Adverse drug reactions problems with spontaneous reporting systems and communicating information to providers to improve reporting rate globally. Working paper from the University of Oxford 2013.
[19]
Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf 2007; 16(2): 223-8.
[http://dx.doi.org/10.1002/pds.1313] [PMID: 16947117]
[20]
Wilbur K. Pharmacovigilance in Qatar: A survey of pharmacists. East Mediterr Health J 2013; 19(11): 930-5.
[http://dx.doi.org/10.26719/2013.19.11.930] [PMID: 24673083]
[21]
Abdel-Latif MM, Abdel-Wahab BA. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia. Saudi Pharm J 2015; 23(2): 154-61.
[http://dx.doi.org/10.1016/j.jsps.2014.07.005] [PMID: 25972735]
[22]
Toska A, Mary G, Kyriakos S, Maria S, Costas D. Adverse drug reaction reporting related to the administration of antibiotics in hospitalized pediatric patients in Greece. Curr Drug Saf 2014; 9(1): 49-55.
[http://dx.doi.org/10.2174/15748863113086660064] [PMID: 24274669]
[23]
Australian Commission on Safety and Quality in Health Care. AURA 2016: First Australian report on antimicrobial use and resistance in human health ACSQHC, Sydney, Australia. 2016. Available at: https://www.safetyandquality.gov.au/publications-and-resources/resource-library/aura-2016-first-australian-report-antimicrobial-use-and-resistance-human-health-full-report
[24]
Wang J, Wang P, Wang X, Zheng Y, Xiao Y. Use and prescription of antibiotics in primary health care settings in China. JAMA Intern Med 2014; 174(12): 1914-20.
[http://dx.doi.org/10.1001/jamainternmed.2014.5214] [PMID: 25285394]
[25]
Kontarakis N, Tsiligianni IG, Papadokostakis P, Giannopoulou E, Tsironis L, Moustakis V. Antibiotic prescriptions in primary health care in a rural population in Crete, Greece. BMC Res Notes 2011; 4: 38.
[http://dx.doi.org/10.1186/1756-0500-4-38] [PMID: 21320356]
[26]
Goosens H, Ferech M, Vander Stichele R, et al. Outpatient antibiotic use in Europe and association with ESAC Project Group. Lancet 2005; 365(9459): 579-87.
[http://dx.doi.org/10.1016/S0140-6736(05)17907-0] [PMID: 15708101]
[27]
Geitona M, Toska A, Latsou D, et al. Antibiotics’ prescribing and pharmacovigilance attitudes among pediatricians and pediatric residents in Cyprus. Pharmacol Pharm 2017; 8(03): 75-84.
[http://dx.doi.org/10.4236/pp.2017.83005]
[28]
Kaushal R, Goldmann DA, Keohane CA, et al. Adverse drug events in pediatric outpatients. Ambul Pediatr 2007; 7(5): 383-9.
[http://dx.doi.org/10.1016/j.ambp.2007.05.005] [PMID: 17870647]
[29]
Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 2008; 47(6): 735-43.
[http://dx.doi.org/10.1086/591126] [PMID: 18694344]
[30]
Adisa R, Omitogun TI. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria. BMC Health Serv Res 2019; 19(1): 926.
[http://dx.doi.org/10.1186/s12913-019-4775-9] [PMID: 31796034]
[31]
Tadvi NA, Alromaih AA, Aldahash AA. Knowledge, attitude and practice of pharmacovigilance in healthcare professionals and medical students in Majmaah, Saudi Arabia Care Centre. Int J Med Res & Health Sci 2018; 7(4): 101-7.
[32]
Lemay J, Alsaleh FM, Al-Buresli L, Al-Mutairi M, Abahussain EA, Bayoud T. reporting of adverse drug reactions in primary care settings in Kuwait: A comparative study of physicians and pharmacists. Med Princ Pract 2018; 27(1): 30-8.
[http://dx.doi.org/10.1159/000487236] [PMID: 29402876]
[33]
Sabblah GT, Akweongo P, Darko D, Dodoo AN, Sulley AM. Adverse drug reaction reporting by doctors in a developing country: A case study from Ghana. Ghana Med J 2014; 48(4): 189-93.
[http://dx.doi.org/10.4314/gmj.v48i4.4] [PMID: 25709133]
[34]
Kanwar S, Mathur SK, Yadav D. A questionnaire based study on the knowledge, attitude and practice of pharmacovigilance among the medical officers working in peripheral areas of Ajmer district, Rajasthan (India). Gal Int J Health Sci Res 2020; 5(1): 84-8.
[35]
Gupta P, Udupa A. Adverse drug reaction reporting and pharmacovigilance: Knowledge, attitudes and perceptions amongst resident doctors. J Pharm Sci & Res 2011; 3(2): 1064-9.
[36]
Hasford J, Goettler M, Munter KH, Müller-Oerlinghausen B. Physicians’ knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol 2002; 55(9): 945-50.
[http://dx.doi.org/10.1016/S0895-4356(02)00450-X] [PMID: 12393084]
[37]
Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood SM. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol 1995; 39(3): 223-6.
[http://dx.doi.org/10.1111/j.1365-2125.1995.tb04440.x] [PMID: 7619660]
[38]
Directive 2001/83/EC of The European Parliament And of The Council of 6 November 2001 on the Community code relating to medicinal products for human use. 2001. Available at: https://ec.europa.eu/health/sites/default/files/files/eudralex/vol-1/dir_2001_83_consol_2012/dir_2001_83_cons_2012_en.pdf.
[39]
Clavenna A, Bonati M. Adverse drug reactions in childhood: A review of prospective studies and safety alerts. Arch Dis Child 2009; 94(9): 724-8.
[http://dx.doi.org/10.1136/adc.2008.154377] [PMID: 19531524]
[40]
Gallo M, Clavenna A, Bonati M, et al. Active surveillance of adverse drug reactions in children in five Italian paediatric wards. Open J Pediatr 2012; 2(2): 111-7.
[http://dx.doi.org/10.4236/ojped.2012.22019]
[41]
Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 2017; 177(9): 1308-15.
[http://dx.doi.org/10.1001/jamainternmed.2017.1938] [PMID: 28604925]
[42]
Choudhary A, Nivedhitha S, Radhakrishna L, et al. Perception of adverse drug reaction among doctors, nurses and pharmacists of a tertiary care rural teaching hospital. Int J Pharmacol 2013; 12: 1.
[43]
Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/outpatients: A systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001; 52(1): 77-83.
[http://dx.doi.org/10.1046/j.0306-5251.2001.01407.x] [PMID: 11453893]

Rights & Permissions Print Cite
Article Metrics
39
1
© 2024 Bentham Science Publishers | Privacy Policy